A high-conviction healthcare investment partnership

We invest in a small number of exceptional healthcare companies, and we work alongside their founders, management teams and aligned investors to create value through critical inflection points.

Our Model

Partner capital first

Our partners commit significant personal capital before aligned investors are invited to participate.

Concentrated by design

We hold focused positions and understand each of them deeply. This is a deliberate choice.

Active ownership

We provide strategic guidance, governance, connections and support across strategy, financing, R&D, commercial execution and exit readiness

We invest in exceptional healthcare companies where our judgement, capital and involvement can materially affect the outcome.

OUR TEAM

Partners who have built, led, governed and exited healthcare companies

Our experience spans clinical medicine, therapeutics, medical devices, healthcare operations, investment and governance. We apply all of it to a deliberately small portfolio.

Marko Bogoievski

Partner

Marko has extensive investment management experience. In his time as CEO of Infratil and Infrastructure Investment Manager H.R.L. Morrison &; Co., funds under management increased from $2.1b to $25b. Marko’s career spans finance, sales and investment management in New Zealand, Australia and the United States, with roles within financial services, FMCG, start-up, corporate, and private equity firms. Marko also holds several public company governance roles. He has a BCA from Victoria University and MBA from the Harvard Graduate School of Business, and is a Fellow Chartered Accountant.

Caroline Quay

Managing Partner

Caroline is a highly experienced healthtech investor. She has led investments into an impressive portfolio of innovative healthtech companies covering medical devices, digital health, drug/biologic product development and diagnostics. Caroline also has more than 20 years’ of strategic and operational experience with innovative high growth public and private healthtech companies. Caroline was Global General Counsel of Fisher &; Paykel Healthcare (FPH:ASX; NZX) and a founding executive of a medical device/therapeutic company, Aroa Biosurgery, which successfully listed on the ASX in 2020 (ARX: ASX).

Caroline started out her career as a mergers and acquisitions, private equity and venture investments lawyer. Caroline was the recipient of the EY/ NZ Asian Leaders’ Scholarship for the EY Darden Programme in 2015 (University of Virginia Darden School of Business). Caroline was also a recipient of the SBC Warburg (now UBS) Scholarship in Finance. She received her Bachelor of Laws degree with Honours and Bachelor of Commerce degree in Accounting and Finance from the University of Auckland.

Dr Scott McPhee

Partner

Scott is a serial entrepreneurial scientist, and has been working on the development of novel medicines since the late 1990’s. He was involved in the first gene therapy programs for neurodegenerative disorders, and the first trials of AAV in the CNS. He was part of the executive leadership and founding team at Asklepios BioPharmaceutical Inc. (acquired by Bayer in 2020). Scott was co-founder of Chatham Therapeutics developing novel treatments for hemophilia A&B (acquired by Baxter Healthcare) and part of the founding team at Bamboo Therapeutics (acquired by Pfizer). He is also a co-founder of Torque Bio. Scott has a Doctorate degree in Molecular Medicine from the University of Auckland and a Masters degree in Public Health from Harvard University.

Dr Ken Chin

Partner

Ken is a medical doctor with over 20 years’ experience and co-founder/owner of various healthcare services and healthcare consultancy businesses. He was a General Practitioner/owner in a large medical practice which was acquired by a healthcare provider in 2022. He is a Fellow of the Royal New Zealand College of General Practitioners (FRNZCGP). Ken has been a consultant providing clinical insight in the assessment of early stage healthcare investments and strategic advice to healthcare businesses since 2016. In his early career, Ken was involved in medical research in Endocrinology and in Urology. He has several research publications in medical sciences. Ken holds a Bachelor of Medicine and Bachelor of Surgery (MBChB) and Bachelor of Human Biology (BHB) from the University of Auckland. He also has a Post Graduate Certificate in Travel Medicine from the University of Otago.

OUR PORTFOLIO

Concentrated by design